News

Diaclone est partenaire d’un projet européen d’envergure associant une douzaine de partenaires de la région de Besançon.

MiMédi Project

Publication date : 2019-08-29

Le Projet MiMédi

MIMEDI: MIcrotechnique pour les MEDicaments Innovants nouvelles solutions technologiques pour optimiser la fabrication de "cellules médicaments"

Diaclone est partenaire d’un projet européen d’envergure associant une douzaine de partenaires de la région de Besançon.

Au sein de ce consortium, Diaclone apporte son expertise et son savoir-faire de plus de 30 ans dans le domaine des anticorps, afin d’aider à la mise en place de processus novateur en matière de tri cellulaire, de détection de contamination, de suivi de populations cellulaires, etc…

Pour plus d'information cliquez ici

Other news

  • ELISPOT
    Diaclone ELISpot assays, tried and trusted by researchers worldwide
    Publication date : 2021-04-01
    Our BEST SELLER the IFNγ ELISpot assay, is widely used in clinical cancer studies and also in COVID-19 research Read more
  • ELISPOT man
    ELISpot Kits - A new format to meet your demands
    Publication date : 2021-02-25
    The Diaclone ELISpot kit range is extended with a new 2 PLATE FORMAT Read more
  • Seed machine
    Monoclonal Antibody Platform
    Publication date : 2021-02-05
    Diaclone and Seed Biosciences collaborate on the development of a new workflow for a faster and more efficient antibody development process Read more
  • Variant
    New! SARS-CoV-2 SPIKE GLYCOPROTEIN RBD VARIANTS
    Publication date : 2021-01-20
    Diaclone is finalizing the development of 3 new SARS-CoV-2 protein variants: SARS-CoV-2 Spike RBD Variant N501Y, SARS-CoV-2 Spike RBD Variant 501Y.V2, SARS-CoV-2 Spike RBD Variant B.1.1.248 Developed in our laboratories in Besançon (France) Read more
  • Covid ELISA set
    New at Diaclone - SARS-CoV-2 ELISA set
    Publication date : 2020-11-24
    Build your own serological assay with our new SARS-CoV-2 ELISA set... Read more
  • Covid rec proteins
    NEW!... RECOMBINANT HUMAN SARS-CoV-2 PROTEINS
    Publication date : 2020-10-15
    Developed in our laboratories in Besançon (France) Read more
  • Spike Protein
    Anti-S1 Domain Spike Protein is now available at Diaclone
    Publication date : 2020-08-03
    Ideal for your COVID-19 studies... Read more
  • IL1RAP
    IL1RAP, a therapeutic target for oncologic treatment
    Publication date : 2020-08-03
    Discover our new IL1RAP clones... Read more
  • Exosomes
    What you need to know about Exosomes
    Publication date : 2020-07-01
    “Huge opportunities”. “Many hurdles”. “Enormous potential”.... Read more
  • cytokines
    Fast track your Covid-19 Research with Diaclone’s CYTOKINES
    Publication date : 2020-05-18
    Essential tools for Cytokine Storm monitoring & Immunotherapy development... Read more
  • Virus
    Essential tools for COVID-19 and Immunotherapy research
    Publication date : 2020-04-02
    Diaclone provides a large panel of research tools, Monoclonal Antibodies and Immunoassays, for measuring the levels of released cytokines triggered by viral infection (cytokine release syndrome - CRS), including a complete range of human IL-6 and TNF-α products. Read more

Product search